跳至主要内容
临床试验/IRCT138809051475N4
IRCT138809051475N4已完成早期 1 期

Pilot study of efficacy of topical nano-liposomal meglumine antimoniate (Glucantime) or paromomycin in combination with systemic Glucantime for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica

Mashhad University of Medical sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 60 years(—)
性别
All

入选标准

  • 1.Male or female aged between 12 to 60 years.
  • 2.Parasitologically proven CL due to L. tropica.
  • 3.History of failure to at least one full course of systemic Glucantime.
  • 4.In general good health based on history and physical examination.
  • 5.Number of lesion at most 4.
  • 6.Lesion size less than 3 cm.
  • 7.Signed informed consent voluntarily and knowingly**.
  • ** Guardian’s signature for volunteer less than 18 years old.
  • Exclusion criteria:
  • 1.Pregnant or lactating women and those who are planning to be pregnant in next 60 days.
  • 2.Use of other types of treatment for CL.
  • 3.Involvement in any other drug or vaccine trial during the study period.
  • 4.Known heart, kidney, liver diseases based on history and physical exam.
  • 5.Abnormal ECG

排除标准

  • 未提供

研究者

相似试验